VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q85369501 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000112.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q85369501‏
024 ‎‡a 0000-0002-1352-0676‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q85369501‏
100 0 ‎‡a Ya-Liang Zhang‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Ya-Liang Zhang‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe‏
670 ‎‡a Author's A patent review of RAF kinase inhibitors (2010-2018)‏
670 ‎‡a Author's Design, synthesis, and biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors‏
670 ‎‡a Author's Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.‏
670 ‎‡a Author's Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation‏
670 ‎‡a Author's Synthesis and Biological Evaluation of 1-Methyl-1H-indole-Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors‏
670 ‎‡a Author's Synthesis and Evaluation of New Quinoxaline Derivatives of Dehydroabietic Acid as Potential Antitumor Agents‏
670 ‎‡a Author's Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents‏
670 ‎‡a Author's Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.‏
670 ‎‡a Author's Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.‏
670 ‎‡a Author's Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.‏
670 ‎‡a Author's Tubulin inhibitors binding to colchicine-site: A Review from 2015 to 2019‏
909 ‎‡a (orcid) 0000000213520676‏ ‎‡9 1‏
919 ‎‡a designsynthesisandbiologicalevaluationofnovel5phenyl1hpyrazolederivativesaspotentialbrafv600einhibitors‏ ‎‡A Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.‏ ‎‡9 1‏
919 ‎‡a synthesisandbiologicalevaluationof1methyl1hindolepyrazolinehybridsaspotentialtubulinpolymerizationinhibitors‏ ‎‡A Synthesis and Biological Evaluation of 1-Methyl-1H-indole-Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors‏ ‎‡9 1‏
919 ‎‡a synthesisandevaluationofnewquinoxalinederivativesofdehydroabieticacidaspotentialantitumoragents‏ ‎‡A Synthesis and Evaluation of New Quinoxaline Derivatives of Dehydroabietic Acid as Potential Antitumor Agents‏ ‎‡9 1‏
919 ‎‡a synthesisanticanceractivityandmoleculardockingstudieson12diarylbenzimidazoleanaloguesasantitubulinagents‏ ‎‡A Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents‏ ‎‡9 1‏
919 ‎‡a synthesisbiologicalevaluationand3dqsarstudiesofnovel5phenyl1hpyrazolcinnamamidederivativesasnovelantitubulinagents‏ ‎‡A Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.‏ ‎‡9 1‏
919 ‎‡a synthesisbiologicalevaluationandmoleculardockingstudiesofnovel1benzeneacyl21methylindol3ylbenzimidazolederivativesaspotentialtubulinpolymerizationinhibitors‏ ‎‡A Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.‏ ‎‡9 1‏
919 ‎‡a synthesismoleculardockingandbiologicalevaluationof1phenylsulphonyl21methylindol3ylbenzimidazolederivativesasnovelpotentialtubulinassemblinginhibitors‏ ‎‡A Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.‏ ‎‡9 1‏
919 ‎‡a tubulininhibitorsbindingtocolchicinesiteareviewfrom2015to‏ ‎‡A Tubulin inhibitors binding to colchicine-site: A Review from 2015 to 2019‏ ‎‡9 1‏
919 ‎‡a novelnicotinoylpyrazolinederivatesbearingnmethylindolemoietyasantitumoragentsdesignsynthesisandevaluation‏ ‎‡A Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation‏ ‎‡9 1‏
919 ‎‡a classofnoveltubulinpolymerizationinhibitorsexerteffectiveantitumoractivityviamitoticcatastrophe‏ ‎‡A A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe‏ ‎‡9 1‏
919 ‎‡a patentreviewofrafkinaseinhibitors2010‏ ‎‡A A patent review of RAF kinase inhibitors (2010-2018)‏ ‎‡9 1‏
919 ‎‡a designsynthesisandbiologicalevaluationof23diphenylcycloalkylpyrazolederivativesaspotentialtubulinpolymerizationinhibitors‏ ‎‡A Design, synthesis, and biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2019‏ ‎‡9 2‏
996 ‎‡2 NTA|36415375X‏
996 ‎‡2 DNB|1163683531‏
996 ‎‡2 LC|n 2011019038‏
996 ‎‡2 DNB|1024014002‏
996 ‎‡2 LC|no2012036700‏
996 ‎‡2 BNF|16254845‏
996 ‎‡2 ISNI|0000000374770211‏
996 ‎‡2 NSK|000754658‏
996 ‎‡2 PLWABN|9810819790305606‏
996 ‎‡2 CYT|AC000637062‏
996 ‎‡2 CYT|AC000647932‏
996 ‎‡2 BIBSYS|90549651‏
996 ‎‡2 CYT|AC000228338‏
996 ‎‡2 ISNI|0000000476907186‏
996 ‎‡2 NTA|36415425X‏
996 ‎‡2 BNF|17882375‏
996 ‎‡2 CYT|AC000319730‏
996 ‎‡2 SUDOC|225850540‏
996 ‎‡2 PLWABN|9811357029405606‏
996 ‎‡2 PLWABN|9810697557405606‏
996 ‎‡2 ISNI|0000000118227092‏
996 ‎‡2 NUKAT|n 2019000307‏
996 ‎‡2 PLWABN|9810698828105606‏
996 ‎‡2 ISNI|0000000458717872‏
996 ‎‡2 PLWABN|9810683807805606‏
996 ‎‡2 ISNI|0000000440111872‏
996 ‎‡2 NSK|000521476‏
996 ‎‡2 CYT|AC000592195‏
996 ‎‡2 CYT|AC000592196‏
996 ‎‡2 CYT|AC000663506‏
996 ‎‡2 CYT|AC000651791‏
996 ‎‡2 ISNI|0000000499107720‏
996 ‎‡2 DNB|1214604331‏
996 ‎‡2 DNB|1089888104‏
996 ‎‡2 SELIBR|388590‏
996 ‎‡2 SUDOC|185844618‏
996 ‎‡2 LC|nb2018005877‏
996 ‎‡2 ISNI|0000000119717587‏
996 ‎‡2 CYT|AC000278104‏
996 ‎‡2 CYT|AC000278105‏
996 ‎‡2 CYT|AC000652098‏
996 ‎‡2 DNB|1250540852‏
996 ‎‡2 DNB|1215865171‏
996 ‎‡2 NSK|000679440‏
996 ‎‡2 PLWABN|9813220058205606‏
996 ‎‡2 PLWABN|9810680175905606‏
996 ‎‡2 NSK|000457544‏
996 ‎‡2 LC|n 2014067576‏
996 ‎‡2 DNB|1045357367‏
996 ‎‡2 J9U|987007335483305171‏
996 ‎‡2 NTA|364154500‏
996 ‎‡2 PLWABN|9814279974505606‏
996 ‎‡2 J9U|987007374757605171‏
996 ‎‡2 BNF|15598489‏
996 ‎‡2 ISNI|0000000496231363‏
996 ‎‡2 DNB|1197561897‏
996 ‎‡2 CAOONL|ncf11653426‏
996 ‎‡2 PLWABN|9813276251605606‏
996 ‎‡2 DNB|1037985508‏
996 ‎‡2 DNB|1157878679‏
996 ‎‡2 CYT|AC000656512‏
996 ‎‡2 CAOONL|ncf10993669‏
996 ‎‡2 CYT|AC000663360‏
996 ‎‡2 DNB|1195067526‏
996 ‎‡2 BNF|17001144‏
996 ‎‡2 NSK|000557205‏
996 ‎‡2 LC|n 99023148‏
996 ‎‡2 CYT|AC000641029‏
996 ‎‡2 BNF|15022787‏
996 ‎‡2 DNB|1309640181‏
996 ‎‡2 DNB|172979765‏
996 ‎‡2 NSK|000164599‏
996 ‎‡2 LC|no2010184317‏
996 ‎‡2 DNB|1151242829‏
996 ‎‡2 SUDOC|092646972‏
996 ‎‡2 J9U|987007360264405171‏
996 ‎‡2 DNB|1319567606‏
996 ‎‡2 NKC|ntk2012678372‏
996 ‎‡2 LC|no2011075877‏
996 ‎‡2 CYT|AC000462864‏
996 ‎‡2 LC|no2011119217‏
996 ‎‡2 NTA|351945784‏
996 ‎‡2 ISNI|0000000034996580‏
996 ‎‡2 NTA|364154284‏
996 ‎‡2 BIBSYS|99023691‏
996 ‎‡2 ISNI|0000000050090607‏
996 ‎‡2 NSK|000731491‏
996 ‎‡2 NSK|000608015‏
996 ‎‡2 DNB|1309893977‏
996 ‎‡2 CYT|AC000652043‏
996 ‎‡2 SUDOC|084130067‏
996 ‎‡2 BNC|981058514644906706‏
996 ‎‡2 CYT|AC000652131‏
996 ‎‡2 NSK|000593739‏
996 ‎‡2 ISNI|0000000110359293‏
996 ‎‡2 PLWABN|9812679246405606‏
996 ‎‡2 DNB|1046184423‏
996 ‎‡2 SUDOC|264982118‏
996 ‎‡2 LC|no2018034689‏
996 ‎‡2 CYT|AC000640105‏
996 ‎‡2 LNL|52480‏
996 ‎‡2 CYT|AC000641330‏
996 ‎‡2 CYT|AC000656554‏
996 ‎‡2 DNB|1077762208‏
996 ‎‡2 PLWABN|9811772638605606‏
996 ‎‡2 LC|n 2019066385‏
996 ‎‡2 CYT|AC000318628‏
996 ‎‡2 BIBSYS|99014217‏
996 ‎‡2 LNL|52477‏
996 ‎‡2 ISNI|0000000504113384‏
996 ‎‡2 DNB|1175215600‏
996 ‎‡2 CYT|AC000270407‏
996 ‎‡2 PLWABN|9810652332205606‏
996 ‎‡2 PLWABN|9811784274305606‏
996 ‎‡2 CYT|AC000321088‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏